Equity Overview
Price & Market Data
Price: $0.673
Daily Change: +$0.0442 / 6.57%
Daily Range: $0.629 - $0.689
Market Cap: $9,257,698
Daily Volume: 17,930
Performance Metrics
1 Week: -10.50%
1 Month: -20.31%
3 Months: 143.9%
6 Months: 300.2%
1 Year: 180.6%
YTD: 8.65%
Company Details
Employees: 4
Sector: Finance
Industry: Financial conglomerates
Country:
Details
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based medical office and mobile patient education solution that provides physicians with dashboard to streamline patient information and business operations; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.